Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Gormley NJ"'
Autor:
Rodriguez LR; Food and Drug Administration, Silver Spring, MD, United States., Gormley NJ; United States Food and Drug Administration, Silver Spring, MD, United States., Lu R; Alumis, Inc., South San Francisco, CA, United States., Amatya AK; United States Food and Drug Administration, Silver Spring, MD, United States., Demetri GD; Dana-Farber Cancer Institute, Boston, MA, United States., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, United States., Mesa RA; Wake Forest Baptist Medical Center, Winston-Salem, NC, United States., Pazdur R; United States Food and Drug Administration, Silver Spring, MD, United States., Sekeres MA; Sylvester Comprehensive Cancer Center, Miami, FL, United States., Shan M; Bayer (United States), Whippany, NJ, United States., Snapinn S; Seattle-Quilcene Biostatistics, LLC., Seattle, WA, United States., Theoret MR; Food and Drug Administration, Silver Spring, MD, United States., Umoja R; American Association For Cancer Research, Washington, DC, United States., Vallejo J; United States Food and Drug Administration, Silver Spring, MD, United States., Warren NJH; American Association For Cancer Research, Washington, DC, United States., Xu Q; United States Food and Drug Administration, Silver Spring, MD, United States., Anderson KC; Dana-Farber Cancer Institute, Boston, MA, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 22. Date of Electronic Publication: 2024 Jul 22.
Autor:
Telaraja D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kasamon YL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Collazo JS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Leong R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Wang K; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Dahmane E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Yang Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Earp J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Grimstein M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rodriguez LR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 05; Vol. 30 (1), pp. 17-22.
Autor:
Donaldson JM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Seddiq M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fusco MJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Singla S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pamuk GE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lee-Alonso RJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Mixter BD; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Goldberg KB; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Drezner N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kanapuru B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lemery SJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Fashoyin-Aje LA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Richardson NC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Singh H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Dec 12; Vol. 13 (12), pp. 2515-2524.
Autor:
Baines AC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Yazdy MS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kasamon YL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ershler R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Jen EY; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kanapuru B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Richardson NC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lane A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Carioti T; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 01; Vol. 29 (15), pp. 2748-2752.
Autor:
Howlader N; Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland., Sharon E; Cancer Therapy and Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Bhattacharya M; Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.; Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland., Ehrlich LA; Office of Oncologic Diseases, U.S. Food and Drug Administration, Silver Spring, Maryland., Richardson NC; Office of Oncologic Diseases, U.S. Food and Drug Administration, Silver Spring, Maryland., Gormley NJ; Office of Oncologic Diseases, U.S. Food and Drug Administration, Silver Spring, Maryland., de Claro RA; Office of Oncologic Diseases, U.S. Food and Drug Administration, Silver Spring, Maryland., Wood AE; Essex Management, National Cancer Institute, Bethesda, Maryland., Mariotto AB; Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland., Cronin KA; Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2023 Jun 01; Vol. 32 (6), pp. 744-747.
Autor:
Baines AC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ershler R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kanapuru B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Xu Q; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Shen G; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ma L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Okusanya OO; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Simpson NE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Nguyen W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Nov 01; Vol. 28 (21), pp. 4629-4633.
Autor:
Maignan K; Flatiron Health Inc, New York, NY, USA., Fashoyin-Aje LA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Torres AZ; Flatiron Health Inc, New York, NY, USA., Fernandes LL; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Gwise T; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Baxi SB; Flatiron Health Inc, New York, NY, USA., Roose JP; Flatiron Health Inc, New York, NY, USA. james.roose@flatiron.com., Rivera DR; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Shen YL; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Kluetz PG; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Gormley NJ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 Apr 19; Vol. 12 (4), pp. 65. Date of Electronic Publication: 2022 Apr 19.
Autor:
Voorhees PM; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Jakubowiak AJ; Myeloma Program, University of Chicago, Chicago, Illinois., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kanapuru B; FDA, Center for Drug Evaluation and Research, Office of Oncologic Disease, Silver Spring, Maryland. bindu.kanapuru@fda.hhs.gov., Baines AC; FDA, Center for Drug Evaluation and Research, Office of Oncologic Disease, Silver Spring, Maryland., Bhatnagar V; FDA, Office of the Commissioner, Office of Medical Products and Tobacco, Oncology Center of Excellence, Silver Spring, Maryland., Ershler R; FDA, Center for Drug Evaluation and Research, Office of Oncologic Disease, Silver Spring, Maryland., Theoret MR; FDA, Office of the Commissioner, Office of Medical Products and Tobacco, Oncology Center of Excellence, Silver Spring, Maryland., Gormley NJ; FDA, Center for Drug Evaluation and Research, Office of Oncologic Disease, Silver Spring, Maryland., Pazdur R; FDA, Office of the Commissioner, Office of Medical Products and Tobacco, Oncology Center of Excellence, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jan 01; Vol. 28 (1), pp. 23-26. Date of Electronic Publication: 2021 Jul 27.
Autor:
Amatya AK; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland. anup.amatya@fda.hhs.gov., Fiero MH; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland., Bloomquist EW; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland., Sinha AK; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland., Lemery SJ; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Singh H; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Ibrahim A; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Donoghue M; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Fashoyin-Aje LA; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., de Claro RA; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Gormley NJ; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Amiri-Kordestani L; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Sridhara R; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Theoret MR; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Kluetz PG; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Pazdur R; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Beaver JA; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Tang S; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Nov 01; Vol. 27 (21), pp. 5753-5756. Date of Electronic Publication: 2021 Jun 11.
Autor:
Kasamon YL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Price LSL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Okusanya OO; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Richardson NC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Li RJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ma L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Wu YT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Theoret M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
The oncologist [Oncologist] 2021 Oct; Vol. 26 (10), pp. 879-886. Date of Electronic Publication: 2021 Jul 01.